Israel-based ConTIPI Medical has closed a round of financing at $3 million, bringing its total funding for its new product to $11 million. The company, which makes nonsurgical and disposable solutions for women with pelvic floor disorders, will use the proceeds for its prescription vaginal ring to treat organ prolapse.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.